Nucleic acid aptamer for specifically recognizing patulin as well as screening method and application of nucleic acid aptamer

Through 18 rounds of SELEX screening and cleavage sensor construction methods, the problems of low specificity and low library fixation efficiency in penicillin detection in the prior art were solved, and efficient and specific identification of nucleic acid aptamer screening and Test.

CN118910062APending Publication Date: 2024-11-08HUBEI NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410884182.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-03
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

It is difficult for the prior art to quickly and conveniently screen out nucleic acid aptamers with high specific recognition ability for penicillin, and the existing methods have problems of low specificity and low library fixation efficiency in small molecule target detection.

Method used

Using 18 rounds of SELEX screening method, nucleic acid aptamers that specifically recognize penicillin were screened using conditions such as streptavidin resin and sodium hydroxide, and were constructed for detection through split sensors, which improved nucleic acid adaptation. body specificity and library fixation efficiency.

Benefits of technology

It has achieved efficient screening of nucleic acid aptamers that specifically recognize penicillin, improving the specificity and efficiency of detection, and providing new ideas for food safety testing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910062A_ABST
    Figure CN118910062A_ABST
Patent Text Reader

Abstract

The invention relates to a nucleic acid aptamer capable of specifically recognizing patulin as well as a screening method and application of the nucleic acid aptamer. The nucleic acid aptamer comprises a nucleotide sequence as follows: 5 'GGGACGACGGTTACCTAGTGGGCGCA AGCCATACGGAGTCGTCCC3'. According to the nucleic acid aptamer screening method for specific recognition of patulin, eighteen rounds of nucleic acid aptamer screening are carried out, and each round of nucleic acid aptamer screening comprises the following steps that an artificially synthesized ssDNA library is dissolved with an SELEX buffer solution, and then a biotin primer is added to obtain a first mixture; and adding the first mixture into streptavidin resin, washing with an SELEX buffer solution for several times, adding 200 [mu] M of patulin, and collecting an eluent. After purification, PCR amplification is carried out, streptavidin resin is added into a product for incubation at room temperature, 0.2 M of sodium hydroxide is added to recover eluent, and a round of nucleic acid aptamer screening is completed. According to the screening method of the nucleic acid aptamer for specifically recognizing patulin, the library is fixed on the resin, and the nucleic acid aptamer on the resin is captured by using free small molecules, so that the library fixing efficiency is high, and the nucleic acid aptamer for specifically recognizing a target can be screened out.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biochemistry, and in particular to a nucleic acid aptamer specifically recognizing patulin and a screening method and application thereof. Background Art

[0002] Patulin (PAT) is a secondary metabolite produced by Penicillium fungi. It was originally studied as a broad-spectrum antibiotic, but its toxicological experiments have shown that PAT has toxicological effects such as affecting fertility, carcinogenicity and immunity. PAT is widely present in fruits such as apples and hawthorns and their corresponding products. In the actual transportation and storage of fruits, fruits are very susceptible to fungal contamination. During the processing into corresponding products, toxins further accumulate. my country's national food safety standards have set a clear limit of 50μg / kg for PAT in food. Therefore, it is necessary to monitor the residues of PAT in agricultural products over a long period of time, which is of great significance to protecting human health.

[0003] The main targets of PAT contamination are fruits and corresponding products, and fruits are in great demand in the existing market. Therefore, the monitoring method must be fast and convenient. At present, the enzyme immunoassay kit is widely used for rapid detection of mycotoxins. The core reagent of the kit is antibody. However, the antibody preparation process is extremely complicated, with a long preparation cycle and large batch differences. In addition, due to the small molecular weight of PAT and its instability in the animal body, it is easy to bind to nucleophilic substances, so it is difficult to prepare highly specific antibodies against PAT. Therefore, it is extremely important to find recognition molecules with similar functions to antibodies.

[0004] Aptamers are single-stranded DNA or RNA prepared by in vitro exponential enrichment (SELEX) technology. They have the advantages of strong specificity, high affinity, wide target range and easy modification. They have extremely broad application prospects in the field of food safety testing. However, as far as small molecule hazards in food are concerned, the preparation of their specific aptamers is a bottleneck problem that needs to be solved urgently. Therefore, it is very necessary to screen out aptamers that can identify small molecule hazards in food.

[0005] Compared with biological macromolecules, it is relatively difficult to screen nucleic acid aptamers that recognize small molecule hazards. Conventional screening methods require the target molecule to be fixed, and the small molecule target must be coupled to the carrier in a certain way before fixation. It is easy to cause the screened nucleic acid aptamers not to recognize the small molecule itself, but to recognize its derivatives, and all the groups of the target cannot be fully exposed, which may also easily lead to the obtained aptamers having low specificity and failing to meet the requirements for screening specific nucleic acid aptamers. Moreover, the efficiency of using magnetic beads for library fixation is not high. The invention patent named "A patulin aptamer and its sensor detection application" mentions content related to patulin aptamers, but does not explicitly mention the number of screening rounds of aptamers, and the monitoring method for whether the screening process is enriched. The document only provides one sequence, and the amount of sequence information is relatively small. Summary of the invention

[0006] Based on this, it is necessary to provide a nucleic acid aptamer that specifically recognizes patulin and a screening method and application thereof to address at least one of the above-mentioned problems.

[0007] In a first aspect, the present application provides a nucleic acid aptamer that specifically recognizes patulin, comprising a nucleotide sequence of: 5'GGGACGACGGGTTACCTAGTGGGCGCAAGCCATACGGAGTCGTCCC3'.

[0008] In the second aspect, the present application provides a method for screening nucleic acid aptamers that specifically recognize patulin, and eighteen rounds of nucleic acid aptamer screening are performed, each round of nucleic acid aptamer screening includes the following steps:

[0009] The artificially synthesized ssDNA library is dissolved in SELEX buffer and then biotin primer is added to obtain a first mixture;

[0010] The first mixture was added to the streptavidin resin, and then washed several times with the SELEX buffer, and then 200 μM patulin was added, and the effluent was collected. After purification, PCR amplification was performed, and the product was added to the streptavidin resin and incubated at room temperature, and 0.2 M sodium hydroxide was added to recover the eluate, completing a round of nucleic acid aptamer screening.

[0011] In certain implementations of the second aspect, after the step of recovering the eluent, the method further comprises:

[0012] The eluate is added to an ultrafiltration tube for concentration, the system solution is replaced with water, and the obtained concentrated solution is added to an emulsion PCR mix for PCR amplification;

[0013] The PCR amplified products are collected and concentrated, the system solution is replaced with a separation buffer, the concentrated products are fixed on the resin and washed several times with the separation buffer to obtain a second mixture;

[0014] 0.2 M sodium hydroxide was added to the second mixture, the effluent was collected, and then the streptavidin resin was added and incubated at room temperature, the eluate was recovered, and then neutralized with hydrochloric acid to obtain a neutralized solution, the neutralized solution was concentrated, and the system solution was replaced with SELEX buffer.

[0015] In combination with the second aspect and the above implementations, in certain implementations of the second aspect, the separation buffer contains 250 mM NaCl and 50 mM HEPES, and the pH value is 7.5.

[0016] In combination with the second aspect and the above implementations, in certain implementations of the second aspect, the SELEX buffer contains 500 mM NaCl, 10 mM MgCl2 and 50 mM HEPES, and the pH value is 7.5.

[0017] In combination with the second aspect and the above implementations, in certain implementations of the second aspect, the molar ratio of the biotin primer to the ssDNA library is 5:1.

[0018] In combination with the second aspect and the above-mentioned implementations, in certain implementations of the second aspect, in the 13th to 18th rounds of screening of the nucleic acid aptamer, before the step of adding 200 μM patulin, the step also includes adding ochratoxin A and tenuisporic acid.

[0019] In combination with the second aspect and the above implementations, in certain implementations of the second aspect, the amount of the ssDNA library used in the first round of screening is 500 pmol, and the amount of the ssDNA library used in subsequent rounds of screening is 100-400 pmol.

[0020] In the third aspect, the present application provides an application method of a nucleic acid aptamer that specifically recognizes patulin, wherein the high-affinity nucleic acid aptamer screened out by the nucleic acid aptamer screening method that specifically recognizes patulin as described in any one of the second aspects of the present application is split into two segments, and the two split human telomeric G quadruplex fragments are added to the ends to construct a split-type sensor.

[0021] The method for screening nucleic acid aptamers that specifically recognize patulin provided by the present invention adopts the method of fixing the library on a resin and using free small molecules to capture the nucleic acid aptamers on the resin. Not only is the library fixation efficiency high, but also nucleic acid aptamers that specifically recognize the target can be screened out. In addition, a sensor based on cleavage-type aptamers is constructed using the screened aptamers to specifically detect PAT, thereby better providing a new idea for PAT detection in actual samples. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 Schematic diagram of the process of screening a nucleic acid aptamer that specifically recognizes patulin in one embodiment of the present invention;

[0023] Figure 2 Schematic diagram of the process of screening and application of patulin nucleic acid aptamers in one embodiment of the present invention;

[0024] Figure 3 This is a comparison chart of the CT value monitoring of each round of screening eluate fluorescence quantitative PCR amplification in one embodiment of the present invention;

[0025] Figure 4 This is a schematic diagram of the alignment of aptamer families in one embodiment of the present invention;

[0026] Figure 5 A schematic diagram of the secondary structure of a nucleic acid aptamer in one embodiment of the present invention;

[0027] Figure 6 A comparative schematic diagram of ITC titration in one embodiment of the present invention;

[0028] Figure 7 This is a schematic diagram of the response of the sensor to different concentrations of PAT in one embodiment of the present invention;

[0029] Figure 8 This is a comparison diagram of the cross-reactions between nucleic acid aptamers and analogs in one embodiment of the present invention. DETAILED DESCRIPTION

[0030] The technical solution of the present invention will be described clearly and completely below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the implementation of the present invention, rather than all implementations. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.

[0031] It should be understood that the schematic drawings are not necessarily drawn to scale. The flowcharts used are exemplary displays of the implementation process of some embodiments of the present invention. It should be understood that the operations of the flowcharts may be implemented out of sequence, and steps without logical contextual relationships may be reversed or implemented simultaneously. In addition, those skilled in the art may add one or more other operations to the flowcharts, or remove one or more operations from the flowcharts, under the guidance of the content of the present invention.

[0032] Reference to an "embodiment" herein means that the particular features, structures, or characteristics being described may be included in at least one implementation of the invention. The appearance of the phrase in various locations in the specification does not necessarily refer to the same embodiment, nor is it necessarily an independent or alternative embodiment that is mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described herein may be combined with other embodiments.

[0033] The embodiment of the first aspect of the present application provides a nucleic acid aptamer that specifically recognizes patulin, and the nucleic acid aptamer comprises a nucleotide sequence: 5'GGGACGACGGGTTACCTAGTGGGCGCAAGCCATACGGAGTCGTCCC3'.

[0034] The embodiment of the second aspect of the present application provides a method for screening a nucleic acid aptamer that specifically recognizes patulin. The entire method requires 18 rounds of nucleic acid aptamer screening, such as Figure 1 As shown, each round of aptamer screening includes the following steps:

[0035] S100: The artificially synthesized ssDNA library is dissolved in SELEX buffer and then biotin primers are added to obtain a first mixture.

[0036] S200: Add the first mixture to the streptavidin resin, wash it several times with the SELEX buffer, add 200 μM patulin, and collect the effluent. After purification, perform PCR amplification, add the product to the streptavidin resin again and incubate it at room temperature, add 0.2 M sodium hydroxide to recover the eluate, and complete a round of nucleic acid aptamer screening.

[0037] Specifically, in certain implementations of the second aspect of the embodiment, after the step of recovering the eluent in S200, the method further includes:

[0038] The eluate is added to an ultrafiltration tube for concentration, the system solution is replaced with water, and the obtained concentrate is added to the emulsion PCR mix for PCR amplification. The product after PCR amplification is collected and concentrated, the system solution is replaced with Separation buffer, and the concentrated product is fixed on the resin and washed several times with Separation buffer to obtain a second mixture. 0.2M sodium hydroxide is added to the second mixture, and then streptavidin resin is added and incubated at room temperature, the eluate is recovered, and after the effluent is collected, it is neutralized with hydrochloric acid to obtain a neutralized solution, the neutralized solution is concentrated, and the system solution is replaced with SELEX buffer.

[0039] Specifically, in combination with the embodiment of the second aspect and the above-mentioned implementation methods, in certain implementation methods of the embodiment of the second aspect, the separation buffer contains 250 mM NaCl and 50 mM HEPES, and the pH value is 7.5.

[0040] Specifically, in combination with the second aspect embodiment and the above implementations, in certain implementations of the second aspect embodiment, the SELEX buffer contains 500 mM NaCl, 10 mM MgCl2 and 50 mM HEPES, and the pH value is 7.5.

[0041] Specifically, in combination with the embodiment of the second aspect and the above-mentioned implementation manner, in certain implementation manners of the embodiment of the second aspect, the molar ratio of the biotin primer to the ssDNA library is 5:1.

[0042] Specifically, in combination with the embodiment of the second aspect and the above-mentioned implementation methods, in certain implementation methods of the embodiment of the second aspect, in the 13th to 18th rounds of screening of the nucleic acid aptamer, before the step of adding 200 μM patulin, the step also includes adding ochratoxin A and tenuisporic acid.

[0043] Specifically, in combination with the embodiment of the second aspect and the above-mentioned implementation methods, in some implementation methods of the embodiment of the second aspect, the amount of the ssDNA library used in the first round of screening is 500 pmol, and the amount of the ssDNA library used in subsequent rounds of screening is 100-400 pmol.

[0044] An embodiment of the third aspect of the present application provides an application method of a nucleic acid aptamer that specifically recognizes patulin, wherein the high-affinity nucleic acid aptamer screened out by the nucleic acid aptamer screening method that specifically recognizes patulin as described in any one of the second aspect of the present application is split into two segments, and the two split human telomeric G quadruplex fragments are added to the ends to construct a split-type sensor.

[0045] The method for screening nucleic acid aptamers that specifically recognize patulin provided by the present invention adopts the method of fixing the library on a resin and using free small molecules to capture the nucleic acid aptamers on the resin. Not only is the library fixation efficiency high, but also nucleic acid aptamers that specifically recognize the target can be screened out. In addition, a sensor based on cleavage-type aptamers is constructed using the screened aptamers to specifically detect PAT, thereby better providing a new idea for PAT detection in actual samples.

[0046] The following is the specific implementation process:

[0047] 1. Screening and high-throughput sequencing of patulin aptamers

[0048] (1) The artificially synthesized ssDNA library (including the nucleotide sequence of 5'GGAGGCTCTCGGGACGAC(N30)GTCGTCCCGATGCTGCAATCGTAA3') was dissolved in SELEX buffer (500mM NaCl, 10Mm MgCl2, 50mM HEPES, pH7.5), and biotin primers (molar ratio to ssDNA library was 5:1) were added for slow denaturation. Add to streptavidin resin (the resin was washed 5 times with SELEX buffer before use), repeatedly fix 6 times, and measure the fixation efficiency. Wash 12 times with SELEX buffer. Add 750μL of PAT with a final concentration of 200μM, collect the effluent, add it to the resin and incubate at room temperature for 15 minutes, and recover the eluate. At the end of each round of screening, take 2μL of the eluate for fluorescent quantitative PCR to monitor the enrichment of the library. The screening process is as follows Figure 2 shown.

[0049] (2) The remaining eluate was used to prepare the second round of library screening. All the eluate was concentrated in an ultrafiltration tube (3 kDa), the system solution was replaced with water, and the concentrate was added to the emulsion PCR mix for PCR amplification (95°C for 2 min, 92°C for 15 s, 59°C for 30 s, 72°C for 45 s, 11 cycles). The PCR product was collected and concentrated by an ultrafiltration tube (10 kDa), and the system solution was replaced with Separation buffer (250 mM NaCl, 50 mM HEPES, pH 7.5). The concentrated PCR product was fixed on the resin (the resin was washed 5 times with Separation buffer before use), washed 10 times with Separation buffer, and 660 μL of 0.2 M sodium hydroxide was added to dissociate the single strands, the effluent was collected, and then added to the resin for incubation at room temperature, the eluate was recovered, and hydrochloric acid was added for neutralization. The neutralized solution was concentrated using an ultrafiltration tube (3 kDa), and the system solution was replaced with SELEX buffer.

[0050] The next day, the library concentration was measured for the next round of screening. The steps for the 1st to 12th rounds of screening were the same. For the 13th to 18th rounds of screening, other toxins (ochratoxin A and succinic acid) were first added for negative screening, and then the PAT target was added for positive screening. The amount of ssDNA library used in the first round of screening was 500 pmol, and the amount of ssDNA library used in the subsequent rounds of screening was 100-400 pmol. The primers used for aptamer screening are shown in Table 1 below:

[0051] Table 1 Primers used for aptamer screening

[0052]

[0053] (3) Real-time fluorescence quantitative PCR monitoring library enrichment. 18μL Q-PCR mix was added to 2μL of elution buffer and Q-PCR was performed. The program was: 95℃ for 2min, 95℃ for 15s, 60℃ for 30s, 72℃ for 45s, 25 cycles. The results were as follows. Figure 3 shown.

[0054] (4) Select the enriched libraries from rounds 10, 15, 17, and 18 and send them to the company for high-throughput sequencing analysis. Perform homology comparison and family analysis on the sequences obtained by sequencing. The results are as follows: Figure 4 Aptamers with more frequent occurrences were selected from the family for secondary structure prediction and affinity analysis.

[0055] 2. Affinity analysis of nucleic acid aptamers

[0056] The aptamers with the highest enrichment times in different families were selected for synthesis, and the synthesized dry powder was dissolved in SELSX buffer (10 μM), and PAT (100 μM) dissolved in SELEX buffer was prepared and sent to the company for ITC titration to analyze the affinity of the aptamer to the target. The secondary structure and ITC titration results are shown in Figure 2. Figure 5 and Figure 6 As shown (PAT-6: 5'GGGACGAGGGTTACCTAGTGGGCGCAA GCCATACGGAGTCGTCCC3').

[0057] 3. Cleavage sensor based on PAT nucleic acid aptamer

[0058] The appropriate high-affinity nucleic acid aptamer was split into two segments, and the two split human telomere G quadruplex fragments were added to the ends. The two segments of nucleic acid aptamers were mixed at 50nM, incubated at 95℃ for 5min, added with ThT, stained at 37℃ for 30min, and incubated with different concentrations of PAT for 30min. The excitation wavelength was 440nm, and the fluorescence intensity at 490nm was detected. The results are as follows Figure 7As shown, the lowest detection level is 0.25 μM and the linear detection range is 0.25 μM-16 μM.

[0059] 4. Specificity analysis of nucleic acid aptamers

[0060] 25 μM patulin, 5-hydroxymethylfurfural, furfural, and ochratoxin A were incubated with the aptamer sensor for 30 min, respectively. The excitation wavelength was 440 nm, and the fluorescence intensity was detected at 490 nm. The results are shown in Figure 8 As shown, the sensor has no cross-reactivity with structural analogs.

[0061] Those skilled in the art will appreciate that all or part of the processes of the above-mentioned embodiments can be implemented by instructing related hardware through a computer program, and the program can be stored in a computer-readable storage medium, wherein the computer-readable storage medium is a disk, an optical disk, a read-only storage memory, or a random access memory, etc.

[0062] The above are only preferred specific implementations of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that can be easily conceived by any technician familiar with the technical field within the technical scope disclosed by the present invention should be covered within the protection scope of the present invention.

Claims

1. A nucleic acid aptamer that specifically recognizes patulin, characterized in that: The nucleotide sequences included are: 5'GGGACGAGGGTTACCTAGTGGGCGCAAGCCATACGGAGTCGTCCC3'.

2. A method for screening nucleic acid aptamers that specifically recognize patulin, characterized in that: Eighteen rounds of aptamer screening were performed to obtain the aptamer that specifically recognizes patulin as claimed in claim 1; each round of aptamer screening included the following steps: The artificially synthesized ssDNA library is dissolved in SELEX buffer and then biotin primer is added to obtain a first mixture; The first mixture was added to the streptavidin resin, and then washed several times with the SELEX buffer, and then 200 μM patulin was added, and the effluent was collected; after purification, PCR amplification was performed, and the product was added to the streptavidin resin and incubated at room temperature, and 0.2 M sodium hydroxide was added to recover the eluate, completing a round of nucleic acid aptamer screening.

3. The method for screening nucleic acid aptamers that specifically recognize patulin according to claim 2, characterized in that: After the step of recovering the eluent, the method further comprises: The eluate is added to an ultrafiltration tube for concentration, the system solution is replaced with water, and the obtained concentrated solution is added to the emulsion PCRmix for PCR amplification; The PCR amplified products are collected and concentrated, the system solution is replaced with a separation buffer, the concentrated products are fixed on the resin and washed several times with the separation buffer to obtain a second mixture; 0.2 M sodium hydroxide was added to the second mixture, the effluent was collected, and then the streptavidin resin was added and incubated at room temperature, the eluate was recovered, and then neutralized with hydrochloric acid to obtain a neutralized solution, the neutralized solution was concentrated, and the system solution was replaced with SELEX buffer.

4. The method for screening nucleic acid aptamers that specifically recognize patulin according to claim 3, characterized in that: The separation buffer contains 250 mM NaCl and 50 mM HEPES, and has a pH value of 7.

5.

5. The method for screening nucleic acid aptamers that specifically recognize patulin according to claim 2, characterized in that: The SELEX buffer contained 500 mM NaCl, 10 mM MgCl2 and 50 mM HEPES, and had a pH of 7.

5.

6. The method for screening nucleic acid aptamers that specifically recognize patulin according to claim 2, characterized in that: The molar ratio of the biotin primer to the ssDNA library is 5:

1.

7. The method for screening nucleic acid aptamers that specifically recognize patulin according to claim 2, characterized in that: In the 13th to 18th rounds of screening of nucleic acid aptamers, the step of adding ochratoxin A and tenuisporic acid also includes adding 200 μM patulin before the step of adding 200 μM patulin.

8. The method for screening nucleic acid aptamers that specifically recognize patulin according to claim 2, characterized in that: The amount of the ssDNA library used in the first round of screening was 500 pmol, and the amount of the ssDNA library used in the subsequent rounds of screening was 100-400 pmol.

9. A method for applying a nucleic acid aptamer that specifically recognizes patulin, characterized in that: The high-affinity nucleic acid aptamer screened by the method for screening nucleic acid aptamers that specifically recognize patulin according to any one of claims 2 to 8 is cleaved into two segments, and the two cleaved human telomeric G quadruplex fragments are added to the ends to construct a cleavage-type sensor.